This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page

A Multi-Disciplinary Team approach in the delivery of Elrexfio®(elranatamab)

Prescribing information can be found at the bottom of the page


Join us on 10 September 2025 to hear from Dr Sally Moore, Consultant Haematologist, Grant Mehrjou, Pharmacist and Jackie Quinn, Clinical Nurse Specialist discussing 'A Multi-Disciplinary Team approach in the delivery of Elrexfio® (elranatamab)' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer. 

Prescribing information can be found at the bottom of the page


Join us on 10 September 2025 to hear from Dr Sally Moore, Consultant Haematologist, Grant Mehrjou, Pharmacist and Jackie Quinn, Clinical Nurse Specialist discussing 'A Multi-Disciplinary Team approach in the delivery of Elrexfio® (elranatamab)' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer. 

Event Date10 September 2025 17:55 BSTDuration2 Hrs 5 AudienceConsultants, Nurses, Pharmacists, Specialist Registrars {{givenName}}%20{{familyName}}%20has%20shared%20a%20resource%20with%20you%3B%20please%20click%20the%20link%20below%3A%0D%0A%0D%0A{{URL}}%0D%0A%0D%0AThank%20you%2C%0D%0A{{givenName}}%20{{familyName}}
Agenda
Meeting Agenda 17:45 - 17:55Joining & Registration
17:55 - 18:00Welcome & Introduction Rupa Pau, Pfizer Ltd
18:00 - 18:45Elrexfio® (elranatamab) Case Studies Sally Moore - Dr
18:45 - 19:15Elrexfio® (elranatamab) Ambulatory Care Grant Mehrjou
19:15 - 19:45Nurse Led Myeloma Clinic with Case Studies Jackie Quinn
19:45 - 20:00Questions & Answers Sally Moore - Dr Grant Mehrjou Jackie Quinn
20:00Meeting Close
Speakers
Event Speakers
Sally Moore, Dr
Sally Moore, DrConsultant Haematologist, University Hospitals Bristol & Weston Foundation Trust

No Biography Available.

Grant Mehrjou
Grant MehrjouPharmacists, Cardiff & Vale Health Boards

No Biography Available.

Jackie Quinn
Jackie QuinnClinical Nurse Specialist, Belfast Health & Social Care Trust

No Biography Available.

Elrexfio®(elranatamab)  

Prescribing Information

ELREXFIO® (elranatamab) has a conditioning marketing authorisation. A conditional marketing authorisation means that further evidence of efficacy and safety data are being collected. New information on this medicinal product will be reviewed when any relevant information of significance becomes available and at least every year. The licensing authority will review new information on this medicine at least every year and update the Summary of Product Characteristics as necessary.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

PP-L1A-GBR-0829 June 2025

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2025 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-11245. January 2025
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024.

YesNo
You are now leaving PfizerPro​​​​​

You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.

PP-UNP-GBR-12070. April 2025​​​​​​​
​​​​​​​
You are now leaving PfizerPro

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer's medicines or business which it has provided or reviewed.

PP-UNP-GBR-12107. April 2025
​​​​​​​